TrialThe British journal of ophthalmology2022

Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease.

Ryo Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.